Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2018 | Prevention is better than cure: identifying the people who are at risk of Alzheimer’s disease

Delphine Boche • 20 Mar 2018
ARUK 2018
Alzheimer’s Disease Dementia

The diagnosis of dementia is commonly made at a stage where it is difficult to slow the progression of the disease. Speaking at the Alzheimer’s Research UK (ARUK) Conference 2018, held in London, UK, Delphine Boche, PhD, from the University of Southampton, Southampton, UK, discusses the importance of identifying people who are at a high risk of developing Alzheimer’s disease, or other types of dementia, and taking measures to impede the progression of the disease.

More from Delphine Boche

What’s in store for research into Alzheimer’s disease?
1:25
What’s in store for research into Alzheimer’s disease?
Delphine Boche • 20 Mar 2018
Microglial proteins in the brain: the good, the bad and the ugly
0:57
Microglial proteins in the brain: the good, the bad and the ugly
Delphine Boche • 20 Mar 2018
Understanding the role of genetics and microglia in Alzheimer’s disease
1:28
Understanding the role of genetics and microglia in Alzheimer’s disease
Delphine Boche • 20 Mar 2018
Moving forwards in Alzheimer’s research: new methods to construct 3D microglial cell cultures
1:15
Moving forwards in Alzheimer’s research: new methods to construct 3D microglial cell cultures
Delphine Boche • 20 Mar 2018

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals